Advanced Cross Linking for Low-grade Myopia
PiXLO2
Non-invasive Phototherapeutic Intrastromal Corneal Collagen Crosslinking (PiXL) for Low-grade Myopia
PiXLO2
Non-invasive Phototherapeutic Intrastromal Corneal Collagen Crosslinking (PiXL) for Low-grade Myopia
Sponsor study identifier
interventional
23
1 country
1
Study Start
April 21, 2016
Actual (reported)Primary Completion
October 31, 2020
Actual (reported)Study Completion
November 30, 2020
Actual (reported)To evaluate the improvement in myopic refractive error and the corneal endothelial safety with a corneal crosslinking treatment regimen for mild myopia. The treatment involves a 4-mm central treatment zone in high oxygen environment without corneal epithelial debridement.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 30, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 21, 2016
Actual (reported)June 20, 2017
Actual (reported)June 23, 2017
Actual (reported)October 31, 2020
Actual (reported)November 30, 2020
Actual (reported)Change from baseline in uncorrected visual acuity
Change from baseline in distance uncorrected visual acuity
1, 3, 6 and 12 months after treatment
Change from baseline in spherical equivalent
Change from baseline in spherical equivalent on subjective distance refraction
1, 3, 6 and 12 months after treatment
Change from baseline in corneal endothelial cell density
12 months after treatment
PiXL treatment with UV irradiation in a central 4 mm homogenous zone of the cornea. For myopia of less than 1.0D, 10 J/cm2 will be used, for higher levels of myopia 15J/cm2 will be used.
PiXL treatment with UV irradiation in a central ring-shaped 4-mm area of the cornea. A central 2-mm zone is left untreated, and the energy is higher towards the periphery of the ring-shaped area, reaching its maximum at 2 mm from the corneal centre. For myopia of less than 1.0D, a maximum of 10 J/cm2 will be used, for higher levels of myopia a maximum of 15J/cm2 will be used.
Phototherapeutic intrastromal corneal collagen cross-linking (PiXL) performed in a high-oxygen environment without corneal epithelial debridement, for treatment of mild myopia.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Department of Clinical Sciences/Ophthalmology, Umeå University
Umeå, 901 85, Sweden
Anders Behndig, MD, PhD
Department of Clinical Sciences/Ophthalmology, Umeå University, Umeå, Sweden
23 participants (actual enrollment reported by the registry).
First Submitted
June 20, 2017
Corneal Refractive Therapy Design Comparison for -4 to -6 Diopter Treatment for Overnight Wear for Myopia
Contact the study team to confirm eligibility.
First Posted
June 23, 2017
Study Start
April 21, 2016
Actual (reported)Primary Completion
October 31, 2020
Actual (reported)Study Completion
November 30, 2020
Actual (reported)Last Updated
December 11, 2020
Record last verified: 2020-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: